切换至 "中华医学电子期刊资源库"
高级检索
中华移植杂志(电子版)

中华移植杂志(电子版) ›› 2023, Vol. 17 ›› Issue (02) : 82 -88. doi: 10.3877/cma.j.issn.1674-3903.2023.02.002

器官捐献

新型冠状病毒感染流行下我国器官捐献者筛选规则是否应时而变？
陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥†()   
  1. 430060　武汉大学人民医院器官移植科；430060　武汉大学人民医院泌尿外科
  • 收稿日期:2023-02-05 出版日期:2023-04-25
  • 通信作者: 周江桥
  • 基金资助:
    国家自然科学基金(81870067，82170664)

Should our screening rules for organ donors be changed under the current COVID-19 pandemic?

Qi Chen, Jiayu Guo, Zhongbao Chen, Xiaoxiong Ma, Tianyu Wang, Jilin Zou, Long Zhang, Zhitao Cai, Tao Qiu, Jiangqiao Zhou†()   

  1. Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan 430060, China; Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China
  • Received:2023-02-05 Published:2023-04-25
  • Corresponding author: Jiangqiao Zhou
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 新型冠状病毒感染流行下我国器官捐献者筛选规则是否应时而变？[J]. 中华移植杂志(电子版), 2023, 17(02): 82-88.

Qi Chen, Jiayu Guo, Zhongbao Chen, Xiaoxiong Ma, Tianyu Wang, Jilin Zou, Long Zhang, Zhitao Cai, Tao Qiu, Jiangqiao Zhou. Should our screening rules for organ donors be changed under the current COVID-19 pandemic?[J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(02): 82-88.

世界范围内新型冠状病毒感染(COVID-19)对器官移植事业产生了重要影响。目前，受到最初COVID-19冲击的器官移植在逐渐恢复，但无法避免的是越来越多的潜在器官捐献者会感染新型冠状病毒。随着中国调整对COVID-19的相关防控政策，对器官捐献者的筛选规则也应谨慎作出调整。在科学选择和获得移植受者知情同意的情况下，考虑应用COVID-19康复供者器官和新型冠状病毒阳性供者的非肺器官的可能性。

关键词: 新型冠状病毒感染, 严重急性呼吸系统综合征冠状病毒2型, 器官移植

Novel coronavirus has exerted an important influence on the cause of organ transplantation worldwide. Organ transplants affected by the initial novel coronavirus infection (COVID-19) are gradually recovering, but it is inevitable that more and more potential organ donors will be infected novel coronavirus. As China adjusts the relevant prevention and control policies on COVID-19, the screening rules for organ donors should also be carefully adjusted. In the case of scientific selection and informed consent of transplant recipients, we should consider the possibility of using organs from COVID-19 rehabilitation donors and non-lung organs from novel coronavirus positive donors.

Key words: COVID-19, SARS-CoV-2, Organ transplantation
1
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention[J]. JAMA, 2020, 323(13):1239-1242.
2
Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19[J]. Nat Rev Microbiol, 2021, 19(3): 141-154.
3
Ahn JH, Kim J, Hong SP, et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19[J]. J Clin Invest, 2021, 131(13): e148517.
4
Zou X, Chen K, Zou J, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection[J]. Front Med, 2020, 14(2):185-192.
5
Ritschl PV, Nevermann N, Wiering L, et al. Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: a By-proxy Society Recommendation Consensus approach[J]. Am J Transplant, 2020, 20(7):1826-1836.
6
中华医学会器官移植学分会. 新型冠状病毒肺炎疫情期间全国器官捐献与移植工作的指导原则(二〇二〇年二月二十三日通过) [J]. 器官移植，2020, 11(2): 179-184.
7
International Registry in Organ Donation and Transplantation. www.irodat.org final numbers 2020 [EB/OL]. (2021-12-01) [2023-02-01].

URL    
8
Shah MB, Lynch RJ, El-Haddad H, et al. Utilization of deceased donors during a pandemic: argument against using SARS-CoV-2-positive donors[J]. Am J Transplant, 2020, 20(7):1795-1799.
9
Di Maira T, Berenguer M. COVID-19 and liver transplantation[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(9):526-528.
10
Gregoire A, Muller L, Nicolas-Robin A. Organ donation and COVID-19: should precautionary principle still apply? [J]. Anaesth Crit Care Pain Med, 2022, 41(4):101120.
11
Shuai H, Chan JF, Hu B, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B．1.1.529 Omicron[J]. Nature, 2022, 603(7902):693-699.
12
Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study[J]. Lancet, 2022, 399(10332):1303-1312.
13
Azzi Y, Bartash R, Scalea J, et al. COVID-19 and solid organ transplantation: a review article[J]. Transplantation, 2021, 105(1):37-55.
14
Chornenkyy Y, Mejia-Bautista M, Brucal M, et al. Liver pathology and SARS-CoV-2 detection in formalin-fixed tissue of patients with COVID-19[J]. Am J Clin Pathol, 2021, 55(6):802-814.
15
Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens[J]. JAMA, 2020, 323(18):1843-1844.
16
Kaul DR, Valesano AL, Petrie JG, et al. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing[J]. Am J Transplant, 2021, 21(8):2885-2889.
17
Galvan NTN, Moreno NF, Garza JE, et al. Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic[J]. Am J Transplant, 2020, 20(11):3113-3122.
18
Domínguez-Gil B, Fernández-Ruiz M, Hernández D, et al. Organ donation and transplantation during the COVID-19 pandemic: a summary of the Spanish experience[J]. Transplantation, 2021, 105(1):29-36.
19
Querrey M, Kurihara C, Manerikar A, et al. Lung donation following SARS-CoV-2 infection[J]. Am J Transplant, 2021, 21(12):4073-4078.
20
Ceulemans LJ, Van Slambrouck J, De Leyn P, et al. Successful double-lung transplantation from a donor previously infected with SARS-CoV-2[J]. Lancet Respir Med, 2021, 9(3):315-318.
21
Kim HJ, Shin DH, Cho WH, et al. Successful lung transplantation from a donor who had recovered from severe acute respiratory syndrome coronavirus 2 pneumonia[J]. Ann Thorac Surg, 2022, 113(5):e351-e354.
22
International Society for Heart and Lung Transplantation. Deceased donor and recipient selection for cardiothoracic transplantation during the COVID-19 pandemic[EB/OL]. (2021-04-12) [2023-02-01].

URL    
23
Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2[J]. N Engl J Med, 2020, 383(6):590-592.
24
Jansen J, Reimer KC, Nagai JS, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids[J]. Cell Stem Cell, 2022, 29(2):217-231.e8.
25
Kates OS, Fisher CE, Rakita RM, et al. Use of SARS-CoV-2-infected deceased organ donors: should we always " just say no？" [J]. Am J Transplant, 2020, 20(7):1787-1794.
26
Bhatti ABH, Nazish M, Khan NY, et al. Living donor liver transplantation during the COVID-19 pandemic: an evolving challenge[J]. J Gastrointest Surg, 2021, 25(12):3092-3098.
27
Kute VB, Godara S, Guleria S, et al. Is it safe to be transplanted from living donors who recovered from COVID-19? Experience of 31 kidney transplants in a multicenter cohort study from India[J]. Transplantation, 2021, 105(4):842-850.
28
Kute VB, Aziz F, Abraham A, et al. Outcomes of living donor kidney transplant after SARS-CoV-2 infection in both the donor and the recipient: a multicenter study[J]. Exp Clin Transplant, 2022, 20(10):908-916.
29
Meshram HS, Kute VB, Patel H, et al. A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: ongoing dilemma between discarding and accepting organs in COVID-19 era！[J]. Transpl Infect Dis, 2021, 23(5):e13683.
30
Hardgrave H, Burdine L, Patel R, et al. Negative COVID-19 plasma PCR following COVID-19+ donor kidney transplant[J]. Transplantation, 2022, 106(9):e422-e423.
31
Lee K, Desai NM, Resnick J, et al. Successful kidney transplantation from a deceased donor with severe COVID-19 respiratory illness with undetectable SARS-CoV-2 in donor kidney and aorta[J]. Am J Transplant, 2022, 22(5):1501-1503.
32
Neidlinger NA, Smith JA, D′Alessandro AM, et al. Organ recovery from deceased donors with prior COVID-19: a case series[J]. Transpl Infect Dis, 2021, 23(2):e13503.
33
Ibrahim MM, Merzkani M, Murad H, et al. Kidney transplantation from COVID-19 deceased donors: new hope on the horizon[J]. Am J Nephrol, 2022, 53(4):331-332.
34
Safa K, Elias N, Gilligan HM, et al. Successful living kidney donation after COVID-19 infection[J]. Transplantation, 2021, 105(1):e4-e5.
35
Tuncer A, Akbulut S, Baskiran A, et al. A recipient and donor both have COVID-19 disease. Should we perform a liver transplant? [J]. J Gastrointest Cancer, 2021, 52(3):1143-1147.
36
Hui KPY, Ng KC, Ho JCW, et al. Replication of SARS-CoV-2 omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract[J]. EBioMedicine, 2022, 83:104232.
37
Ushiro-Lumb I, Callaghan CJ, Pettigrew GJ, et al. Transplantation of organs from SARS-CoV-2 RNA positive deceased donors: the UK experience so far[J]. Transplantation, 2022, 106(9):e418-e419.
38
Jashari R, Van Esbroeck M, Vanhaebost J, et al. The risk of transmission of the novel coronavirus (SARS-CoV-2) with human heart valve transplantation: evaluation of cardio-vascular tissues from two consecutive heart donors with asymptomatic COVID-19[J]. Cell Tissue Bank, 2021, 22(4):665-674.
39
Peghin M, Grossi PA. COVID-19 positive donor for solid organ transplantation[J]. J Hepatol, 2022, 77(4):1198-1204.
40
Madgula AS, Nestasie M, Link C, et al. Tackling the paradox of orthotropic heart transplantation from SARS-CoV-2 positive donors: a single center experience[J]. J Heart Lung Transplant, 2022, 41(11):1650-1653.
41
Mullan CW, Komlo C, Clark KAA, et al. Survival after heart transplantation from SARS-CoV-2-positive donors[J]. JACC Heart Fail, 2022, 10(11):874-876.
42
de la Villa S, Valerio M, Salcedo M, et al. Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation[J]. Transpl Infect Dis, 2021, 23(5):e13664.
43
Barros N, Ermel A, Mihaylov P, et al. Deceased donor liver transplantation from a SARS-CoV-2-positive donor to a SARS-CoV-2-positive recipient[J]. Liver Transpl, 2021, 27(12):1849-1851.
44
Romagnoli R, Gruttadauria S, Tisone G, et al. Liver transplantation from active COVID-19 donors: a lifesaving opportunity worth grasping？[J]. Am J Transplant, 2021, 21(12):3919-3925.
45
Manzia TM, Gazia C, Lenci I, et al. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor[J]. Am J Transplant, 2021, 21(7):2600-2604.
46
La Hoz RM, Mufti AR, Vagefi PA. Short-term liver transplant outcomes from SARS-CoV-2 lower respiratory tract NAT positive donors[J]. Transpl Infect Dis, 2022, 24(1):e13757.
47
Yetmar ZA, Ranganath N, Huebert RC, et al. Successful liver transplantation from a SARS-CoV-2 positive donor to a positive recipient: potential role of monoclonal antibodies[J]. Transplantation, 2022, 106(3):e181-e182.
48
Nguyen MC, Lee EJ, Avery RK, et al. Transplant of SARS-CoV-2-infected living donor liver: case report[J]. Transplant Direct, 2021, 7(8):e721.
49
Wall AE, McKenna GJ, Onaca N, et al. Utilization of a SARS-CoV-2-positive donor for liver transplantation[J]. Proc (Bayl Univ Med Cent), 2021, 35(1):62-63.
50
Goss MB, Leung DHB, Pouch SM, et al. A new chapter in an evolving pandemic: successful pediatric liver transplantation with SARS-CoV-2+ donors[J]. Pediatr Transplant, 2022, 26(8):e14407.
51
Azhar A, Kleiboeker S, Khorsandi S, et al. Detection of transmissible severe acute respiratory syndrome coronavirus-2 from deceased kidney donors: implications for kidney transplant recipients[J]. Transplantation, 2023, 107(2):e65-e67.
52
Sandes-Freitas TV, De Almeida ERB, Garcia RCFG, et al. Organ transplant from SARS-CoV-2-positive donors: a brazilian experience[J]. Transplant Proc, 2022, 54(10):2635-2637.
53
Molnar MZ, Hall IE, Raghavan D, et al. Kidney transplantation from SARS-CoV-2-positive deceased donor[J]. Am J Transplant, 2022, 22(4):1280-1282.
54
Koval CE, Poggio ED, Lin YC, et al. Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: a report of 10 cases[J]. Am J Transplant, 2021, 21(11):3743-3749.
55
Perlin DV, Dymkov IN, Terentiev AV, et al. Is kidney transplantation from a COVID-19-positive deceased donor safe for the recipient？[J]. Transplant Proc, 2021, 53(4):1138-1142.
56
Puodziukaite L, Serpytis M, Kundrotaite A, et al. Kidney transplantation from a SARS-CoV-2-positive donor for the recipients with immunity after COVID-19[J]. Transpl Infect Dis, 2021, 23(4):e13666.
57
Sanchez-Vivaldi JA, Patel MS, Shah JA, et al. Short-term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors[J]. Transpl Infect Dis, 2022, 24(4):e13890.
58
Covarrubias K, Brubaker AL, Mekeel K, et al. Single-center experience on nonlung solid organ transplantation from SARS-CoV-2-positive donors[J]. Transplantation, 2023, 107(1):e41-e42.
59
Sigler R, Shah M, Schnickel G, et al. Successful heart and kidney transplantation from a deceased donor with PCR positive COVID-19[J]. Transpl Infect Dis, 2021, 23(5):e13707.
60
Koval CE, Eltemamy M, Poggio ED, et al. Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: a single-center experience[J]. Am J Transplant, 2022, 22(12):2903-2911.
61
Perlin D, Shmanev A, Perlina A, et al. Kidney transplantation from COVID-19 deceased donor[J]. Urol Case Rep, 2021, 37:101617.
62
Dhand A, Gass A, John D, et al. Long-term and short-term outcomes of solid organ transplantation from donors with a positive SARS-CoV-2 test[J]. Transplantation, 2022, 106(8):e384-e385.
63
Jayasekera CR, Vikram HR, Rifat Z, et al. Solid organ transplantation from SARS-CoV-2-infected donors to uninfected recipients: a single-center experience[J]. Transplant Direct, 2022, 8(2):e1286.
64
Wille D, Heinzelmann J, Kehlen A, et al. New safety aspects in corneal donation-studies on SARS-CoV-2-positive corneal donors[J]. J Clin Med, 2022, 11(12):3312.
65
Ferrari S, Del Vecchio C, Leonardi A, et al. Detection of severe acute respiratory syndrome coronavirus 2 in corneas from asymptomatic donors[J]. Acta Ophthalmol, 2021, 99(7):e1245-e1246.
66
Mahalingam K, Angmo D, Kakkar A, et al. Analysis of SARS-CoV-2 in corneal tissue of deceased asymptomatic novel coronavirus disease 2019 donors[J]. Cornea, 2022, 41(12):1559-1563.
67
Bayyoud T, Iftner A, Iftner T, et al. Absence of severe acute respiratory syndrome-coronavirus-2 RNA in human corneal tissues[J]. Cornea, 2021，40(3):342-347.
68
Salz AK, Acharya M, Hofmann N, et al. Risk of SARS-CoV-2 virus transmission from donor corneal tissue: a review[J]. Indian J Ophthalmol, 2021, 69(6):1592-1597.
69
Ferrari S, Del Vecchio C, Bosio L, et al. Absence of severe acute respiratory syndrome coronavirus 2 RNA in human corneal donor tissues: implications for transplantation[J]. Cornea, 2021, 40(3):e3-e4.
70
Corman VM, Rabenau HF, Adams O, et al. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission[J]. Transfusion, 2020, 60(6):1119-1122.
71
Cappy P, Candotti D, Sauvage V, et al. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation[J]. Blood, 2020, 136(16):1888-1891.
72
Leclerc M, Fourati S, Menouche D, et al. Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors[J]. Lancet Haematol, 2021, 8(3):e167-e169.
73
Koç A, Doğru Ö, Eker N, et al. Hematopoietic stem cell transplantation to a patient with acute myeloid leukemia from a sibling donor positive for SARS-CoV-2 by RT-PCR test[J]. Turk J Haematol, 2022, 39(2):150-151.
74
Anurathapan U, Apiwattanakul N, Pakakasama S, et al. Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling[J]. Bone Marrow Transplant, 2020, 55(12):2359-2360.
75
Schold JD, Koval CE, Wee A, et al. Utilization and outcomes of deceased donor SARS-CoV-2-positive organs for solid organ transplantation in the United States[J]. Am J Transplant, 2022, 22(9):2217-2227.
76
Brasil Sistema Nacional de Transplantes. Gerenciamento do risco sanitário da epidemia de COVID-19 (SARS-CoV-2) para a doação de órgãos, tecidos e células-tronco hematopoiéticas. Nota Técnica[EB/OL]. (2022-03-24) [2023-01-31].

URL    
77
Viana LA, Cristelli MP, Mendes Leite V, et al. Transplanting kidneys from donors with SARS-CoV-2 RNA positivity in Brazil: early success under a detailed surveillance approach[J]. Transplantation, 2022, 106(12):e517-e519.
78
Eichenberger EM, Coniglio AC, Milano C, et al. Transplanting thoracic COVID-19 positive donors: an institutional protocol and report of the first 14 cases[J]. J Heart Lung Transplant, 2022, 41(10):1376-1381.
79
Grossi AA, Nicoli F, Cardillo M, et al. Liver transplantation from active COVID-19 donors: is it ethically justifiable？[J]. Transpl Infect Dis, 2022, 24(4):e13846.
[1] 李安琪, 徐祎琳, 向天新. 新型冠状病毒感染后肺纤维化病变诊治进展[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 294-298.
[2] 江文诗, 何湘湘. 全球及我国器官捐献发展特征分析与学科建设[J]. 中华移植杂志(电子版), 2023, 17(05): 280-286.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[4] 戚若晨, 马帅军, 韩士超, 王国辉, 刘克普, 张小燕, 杨晓剑, 秦卫军. 肾移植术后新型冠状病毒感染单中心诊疗经验[J]. 中华移植杂志(电子版), 2023, 17(04): 232-239.
[5] 巨春蓉, 何建行, 钟南山. 咪唑立宾在器官移植领域的应用及展望[J]. 中华移植杂志(电子版), 2023, 17(04): 227-231.
[6] 中国康复医学会器官移植康复专业委员会. 成人实体器官移植后糖尿病管理专家共识[J]. 中华移植杂志(电子版), 2023, 17(04): 205-220.
[7] 艾紫叶, 李玲, 何重香, 黄伟, 叶啟发. 猪器官异种移植研究进展[J]. 中华移植杂志(电子版), 2023, 17(03): 186-191.
[8] 杨锦然, 李新长, 何小平, 傅俊, 龙成美, 陈志铭. 不破坏膈肌式肝肾联合获取术总结分析[J]. 中华移植杂志(电子版), 2023, 17(03): 146-151.
[9] 刘路浩, 苏泳鑫, 曾丽娟, 张鹏, 陈荣鑫, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正. 新型冠状病毒感染疫情期间肾移植受者免疫抑制剂服药依从性研究[J]. 中华移植杂志(电子版), 2023, 17(03): 140-145.
[10] 刘剑戎, 范明明, 郭煜. 器官捐献者转介时的临床特征分析[J]. 中华移植杂志(电子版), 2023, 17(03): 129-133.
[11] 陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 心肾联合移植三例[J]. 中华移植杂志(电子版), 2023, 17(02): 124-127.
[12] 王红敏, 谢云波, 王彦虎, 王福生. 间充质干细胞治疗新冠病毒感染的临床研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 247-256.
[13] 李金璞, 饶向荣. 抗病毒药物和急性肾损伤[J]. 中华肾病研究电子杂志, 2023, 12(05): 287-290.
[14] 徐静媛, 谢波, 邱海波, 杨毅. 《重症医学》课程思政建设的探索与实践[J]. 中华重症医学电子杂志, 2023, 09(03): 265-268.
[15] 田丹阳, 刘小璇, 叶珊, 马新然, 樊东升, 傅瑜. 新型冠状病毒感染疫情对神经内科住院医师规范化培训的影响[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 499-504.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号